BR100 Increased By (0.08%)
BR30 Increased By (0.1%)
KSE100 Increased By (0.14%)
KSE30 Increased By (0.19%)
AGHA 6.53 Increased By ▲ 0.21 (3.32%)
BECO 4.43 Increased By ▲ 0.16 (3.75%)
BML 62.45 No Change ▼ 0.00 (0%)
BOP 31.42 Increased By ▲ 0.19 (0.61%)
CNERGY 11.79 Increased By ▲ 0.20 (1.73%)
CSIL 6.02 Increased By ▲ 0.30 (5.24%)
FCCL 60.80 Decreased By ▼ -0.74 (-1.2%)
FFL 14.91 Decreased By ▼ -0.11 (-0.73%)
FNEL 1.25 Increased By ▲ 0.02 (1.63%)
KEL 6.31 Increased By ▲ 0.05 (0.8%)
KOSM 5.72 Increased By ▲ 0.16 (2.88%)
LOTCHEM 24.70 Increased By ▲ 0.02 (0.08%)
MLCF 102.99 Decreased By ▼ -1.09 (-1.05%)
NBP 174.70 Decreased By ▼ -0.58 (-0.33%)
NCPL 52.89 Increased By ▲ 0.12 (0.23%)
NPL 54.66 Increased By ▲ 0.54 (1%)
OGDC 313.88 Increased By ▲ 0.49 (0.16%)
PACE 9.33 Increased By ▲ 0.13 (1.41%)
PAEL 35.55 Decreased By ▼ -0.25 (-0.7%)
PIBTL 13.65 Increased By ▲ 0.18 (1.34%)
PPL 222.00 Increased By ▲ 0.19 (0.09%)
PRL 80.50 Increased By ▲ 1.42 (1.8%)
PTC 47.01 Increased By ▲ 0.16 (0.34%)
SSGC 23.98 Increased By ▲ 0.11 (0.46%)
TBL 9.27 Decreased By ▼ -0.04 (-0.43%)
TELE 7.45 Increased By ▲ 0.06 (0.81%)
TPL 24.70 Decreased By ▼ -0.41 (-1.63%)
TPLP 12.99 Increased By ▲ 0.48 (3.84%)
TREET 26.08 Decreased By ▼ -0.17 (-0.65%)
TRG 53.99 Increased By ▲ 0.55 (1.03%)
Markets

CBOT corn may retest resistance at $3.78-1/2

Published Updated

SINGAPORE: CBOT December corn may seek a support at $3.68-3/4 per bushel and then retest a resistance at $3.78-1/2.

The support and the resistance are identified respectively as the 23.6 percent and the 50 percent projection levels of an upward wave C from $3.60-1/2.

Compared to the first wave labelled A, the wave C looks too short to complete. Five smaller waves make up the wave C, with third wave labelled 3 expected to extend.

A break below $3.68-3/4, which is unlikely, could cause a loss limited to $3.65-3/4. A break above $3.74-1/4 could confirm the continuation of the uptrend towards the range of $3.78-1/2 to $3.82-1/2.

Wang Tao is a Reuters market analyst for commodities and energy technicals. The views expressed are his own.

No information in this analysis should be considered as being business, financial or legal advice. Each reader should consult his or her own professional or other advisers for business, financial or legal advice regarding the products mentioned in the analyses.

Copyright Reuters, 2018

Comments

Comments are closed for this article.